tirzepatide and wegovy Zepbound (tirzepatide) superior to (semaglutide), says Lilly-funded clinical trial Wegovy (Semaglutide) vs Tirzepatide: What's

Or BMI of 27 or higher with one of these: High blood pressure High cholesterol Sleep problems Heart problems Type 2 diabetes or prediabetes Must have tried to lose weight before without success

Tirzepatide's dual GIP/GLP-1 mechanism provides superior insulin sensitization compared to single-target medications

The goal is not simply to reach a stable dose, but to achieve and sustain clinically meaningful weight loss over time

Montaser E, Farhy LS, Kovatchev BP

While tirzepatide's dual-receptor action typically produces faster weight loss, semaglutide remains a validated, cost-effective choice for patients who want to start smaller and pay less upfront